850105P

20:4 Lyso PI

1-arachidonoyl-2-hydroxy-sn-glycero-3-phosphoinositol (ammonium salt), powder

• Synonyme(s) : 1-(5Z,8Z,11Z,14Z-eicosatetraenoyl)-2-hydroxy-sn-glycero-3-phospho-(1′-myo-inositol); PI(20:4(5Z,8Z,11Z,14Z)/0:0)
• Formule empirique (notation de Hill): C₂₉H₅₂NO₁₂P
• Numéro CAS: 1246430-04-5
• Poids moléculaire : 637.70
• Code UNSPSC : 51191904
• Nomenclature NACRES : NA.25

Propriétés

• Pureté: >99% (LPI; may contain up to 10% of the 2-LPI isomer, TLC)
• Forme: powder
• Conditionnement: pkg of 1 × 100 μg (with stopper and crimp cap (850105P-100ug)); pkg of 1 × 500 μg (with stopper and crimp cap (850105P-500ug))
• Fabricant/nom de marque: Avanti Research^™ - A Croda Brand 850105P
• Type de lipide: phospholipids
• Conditions d'expédition: dry ice
• Température de stockage: −20°C
• Chaîne SMILES: [H][C@@](COP([O-])(O[C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](O)[C@H]1O)=O)(O)COC(CCC/C=C\C/C=C\C/C=C\C/C=C\CCCCC)=O.[NH4+]

Description

Description générale

20:4 Lyso PI or 1-arachidonoyl-2-hydroxy-sn-glycero-3-phosphoinositol (ammonium salt) is an ammonium salt of phosphoinositol, with substitution of arachidonic acid at the sn-1 position of the glycerol backbone.

Increased circulating levels of L-alpha-lysophosphatidylinositol (LPI) are associated with cancer and LPI is a potent ligand for the G-protein-coupled receptor GPR55.

Application

20:4 Lyso PI or has been used as a lipid standard for optimization of the liquid chromatography mass spectrometry (LC-MS) method conditions.

Conditionnement

2 mL Amber Serum Vial with Stopper and Crimp Cap (850105P-100ug)

2 mL Amber Serum Vial with Stopper and Crimp Cap (850105P-500ug)

Informations légales

Avanti Research is a trademark of Avanti Polar Lipids, LLC

Informations sur la sécurité

• Code de la classe de stockage: 11 - Combustible Solids
• Classe de danger pour l'eau (WGK): WGK 3
• Point d'éclair (°F): No data available
• Point d'éclair (°C): No data available